Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$2,462,740.00
Jul 1, 2017
Respiratory mucosal immunity and novel vaccination strategies against pulmonary tuberculosis
$270,000.00
Jun 14, 2017
Viral sensitizer technology for increasing yield of vaccines produced in cell culture
CRDPJ
$25,000.00
Jun 14, 2017
Wrinkled non-spherical microparticles as a new microcarrier for cell culture applications in Sanofi Pasteur
EGP
$25,000.00
Jun 14, 2017
Quantitative biodistribution of viral nanoparticles by nuclear imaging
EGP
$249,994.00
Jun 1, 2017
Influence of pre-existing HIV cross-reactive CD4 T cells on vaccine responses to new Env immunogens
$250,000.00
Jun 1, 2017
Developing the ACT-VEC as an HIV therapeutic vaccine and cure approach
$250,000.00
Jun 1, 2017
Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies
$70,000.00
May 18, 2017
Development of Orf virus (ORFV) as a multivalent vaccine vector platform against Toxoplasma gondii
CGSD2
$160,000.00
May 10, 2017
Development of fish cell lines for use in ecotoxicology and fish health: the case for fish olfactory cells
RGPIN
$140,000.00
May 10, 2017
A novel Approach to Target Trypanosome, Leishmania and Superbugs to the Lysosomal Compartment
RGPIN